Home Boxes
Camlipixant (BLU-5937)
Developing a Promising Therapeutic Candidate
Advancing a potential solution for refractory chronic cough.
Clinical Trials
Investigating the Promise of Camlipixant
Ongoing Phase 3 trials, CALM-1 and CALM-2, in refractory chronic cough.
Patients
Patients are at the Heart of What We Do
Committed to patients struggling with refractory chronic cough.
Careers
Help us
Transform
Lives
Join our experienced team of diverse and resilient professionals dedicated to developing breakthrough treatments.